BSX Earnings
Latest Revenue5.4B
Latest Net Income905.0M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.62 | 5.4B | 905.0M | +7.5% | +14.8% |
| Q1 2026 | $0.90 | 5.2B | 1.3B | +11.6% | +95.7% |
| Q4 2025 | $0.45 | 5.3B | 670.0M | +15.9% | +18.4% |
| Q3 2025 | $0.51 | 5.1B | 756.0M | +20.3% | +59.4% |
| Q2 2025 | $0.54 | 5.1B | 795.0M | +22.8% | +145.5% |
| Q1 2025 | $0.46 | 4.7B | 672.0M | +20.9% | +35.3% |
| Q4 2024 | $0.38 | 4.6B | 562.0M | +22.4% | +11.8% |
| Q3 2024 | $0.32 | 4.2B | 469.0M | +19.3% | -5.9% |
| Q2 2024 | $0.22 | 4.1B | 322.0M | — | — |
| Q1 2024 | $0.34 | 3.9B | 493.0M | — | — |
| Q4 2023 | $0.34 | 3.7B | 504.0M | — | — |
| Q3 2023 | $0.34 | 3.5B | 505.0M | — | — |
Boston Scientific (BSX) — Earnings